Boehringer Ingelheim’s SENVELGO gets EU marketing authorization for feline diabetes treatment

Pallavi Madhiraju- November 23, 2023 0

The European Commission has granted marketing authorization to Boehringer Ingelheim for SENVELGO (active ingredient: velagliflozin), a groundbreaking development in the treatment of feline diabetes across ... Read More

Zydus Lifesciences gets FDA tentative approval for Invokamet generic

Pallavi Madhiraju- February 22, 2023 0

Zydus Lifesciences said that its subsidiary Zydus Pharmaceuticals (USA) has been granted tentative approval for Canagliflozin and Metformin Hydrochloride Tablets, 50mg/500mg, 50mg/1,000mg, 150mg/500mg, and 150mg/1,000mg ... Read More

Fruit juices may increase risk of developing Type 2 Diabetes

pharmanewsdaily- March 23, 2018 0

As per the research done by a group of scientists, it was revealed that drinking fruit juices could increase the risk of developing Type 2 ... Read More

FDA approves CeloNova Cobra PzF coronary stent system

pharmanewsdaily- March 3, 2017 0

The US Food and Drug Administration (FDA) has approved the Cobra PzF nanocoated coronary stent system developed by Texas medical device maker CeloNova BioSciences. Approval ... Read More

Smokers with Diabetes have high risk of early death!

pharmanewsdaily- November 30, 2016 0

As per the recent study by Kavita Garg, an Indian-origin researcher at the University of Colorado-Denver in US, diabetic persons with heavy smoking habit have ... Read More